Scrip Poll Result: Brexit Would Be Bad For UK Life Science Industry
This article was originally published in Scrip
Executive Summary
It's official. The vast majority of you think the UK life sciences industry would hit stormy seas should the country decide to leave the relatively safe haven of the European Union.
You may also be interested in...
'We Cannot Afford To Be An Island': Bayer's UK CEO Shares Anti-Brexit Opinion
In the lead up to the June 23 referendum to decide whether Britain should leave or remain in the European Union, Dr. Alexander Moscho, CEO of Bayer UK & Ireland, shares his opinion on how leaving the EU could be a setback for life sciences and impact patients significantly in regard to access to medicines.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.